Phase I Dose Escalation Study for Neoadjuvant Radiosurgery

Phase I Dose Escalation Study for Neoadjuvant Radiosurgery

Cleveland Clinic

2 months
9 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Dr. Erin Murphy, MD of Cleveland Clinic explains the phase I dose escalation study for neoadjuvant radiosurgery for large brain metastases.

_____

Preoperative (neoadjuvant) stereotactic radiosurgery (SRS) with dose escalation followed by surgical resection for brain metastases > 2 cm yielded local control comparable to that with postoperative SRS or whole-brain radiation therapy (WBRT) — with the benefits of acceptable acute toxicity and a low incidence of leptomeningeal disease.

These preliminary findings from a Cleveland Clinic prospective phase 1/2 clinical trial were presented Sept. 15 at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO).

“So far we have seen excellent results with radiation doses higher than the current SRS standards,” says lead investigator Erin Murphy, MD, a radiation oncologist in Cleveland Clinic’s Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center. “If findings continue to be positive, we anticipate that new standards can be adopted to safely save more patients from recurring disease.”

Read the rest here: https://consultqd.clevelandclinic.org/high-dose-neoadjuvant-radiosurgery-for-brain-metastases-appears-safe-effective-in-early-results-from-phase-1-2-study/

Up Next Autoplay
How does this affect treatment?
How does this affect treatment?
Category: Colorectal Cancer
8 Views
Cleveland Clinic 2 months
Is this truly safe?
Is this truly safe?
Category: Colorectal Cancer
2 Views
Cleveland Clinic 2 months
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Category: Colorectal Cancer
12 Views
Cleveland Clinic 2 months
How does this affect clinicians today?
How does this affect clinicians today?
Category: Brain Cancer
5 Views
Cleveland Clinic 2 months
Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells
Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells
Category: Brain Cancer
13 Views
Cleveland Clinic 2 months
Nomograms on salvage radiotherapy
Nomograms on salvage radiotherapy
Category: Pancreatic Cancer
2 Views
Cleveland Clinic 2 months
How does it differ from previously published nomograms?
How does it differ from previously published nomograms?
Category: Pancreatic Cancer
1 Views
Cleveland Clinic 2 months
Impact of Post-Prostatectomy Prostate Specific Antigen (PSA) Kinetics on Outcomes of Salvage Radiotherapy
Impact of Post-Prostatectomy Prostate Specific Antigen (PSA) Kinetics on Outcomes of Salvage Radiotherapy
Category: Prostate Cancer
1,839 Views
Cleveland Clinic 2 months
How this will affect clinicians today
How this will affect clinicians today
Category: Other
3 Views
Cleveland Clinic 2 months
Why Dose Escalation?
Why Dose Escalation?
Category: Other
5 Views
Cleveland Clinic 2 months